Related Experiment Video
Updated: Jan 7, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Still the same tune: unchanged antibiotic-associated adverse event rates support the need for outpatient
Ganga Moorthy1,2, Matthew P Kronman3,4
1Department of Pediatrics, Duke School of Medicine, Box 3352 DUMC, Durham, NC 27710.
Insights
Pediatric antibiotic-associated adverse events saw an overall annual decrease from 2019-2023. However, 2023 events returned to historical levels, highlighting the need for continued antimicrobial stewardship.
Area of Science:
- Pediatric Health
- Infectious Diseases
- Pharmacology
Background:
- Antibiotic-associated adverse events (AAEs) are a significant concern in pediatric populations.
- The period 2019-2023 encompassed the COVID-19 pandemic, a major disruptor of healthcare patterns.
Purpose of the Study:
- To analyze trends in pediatric AAEs from 2019 to 2023.
- To assess the impact of the COVID-19 pandemic on these trends.
- To evaluate the ongoing need for outpatient antimicrobial stewardship.
Main Methods:
- Retrospective analysis of pediatric AAE data from 2019-2023.
- Statistical comparison of annual AAE rates.
- Evaluation of pandemic-related influences on AAE occurrence.
Main Results:
- A decrease in the overall average annual number of pediatric AAEs was observed during the study period.
- However, AAEs in 2023 alone were comparable to pre-pandemic historical numbers.
- The COVID-19 pandemic influenced the observed trends in pediatric AAEs.
Conclusions:
- Despite an overall decrease, pediatric AAEs in 2023 indicate a return to baseline levels.
- Sustained outpatient antimicrobial stewardship programs are crucial for managing pediatric AAEs.
- Pandemic-era changes necessitate continued vigilance in antimicrobial use.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antibiotic Selection
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Development of Antibiotic Resistance
Urine Studies II: Urine Culture and Sensitivity Test

